Skip to main content

Use of Cervista HPV HR assay for detection of human papillomavirus in samples with hybrid capture borderline negative results

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Galan-Sanchez F, Rodriguez-Iglesias MA. Use of Cervista HPV HR assay for detection of human papillomavirus in samples with hybrid capture borderline negative results. APMIS 2010; 118: 681–4.

We have evaluated Cervista HPV HR for papillomavirus detection in 65 samples previously borderline negative by the hybrid capture method (Digene), using InnoLipa and sequencing as confirmatory techniques. Nine samples were found to be positive by Cervista HPV HR, of which five (7.6%) were confirmed by InnoLipa. Four samples (6.1%) were false positive, of which three samples were reactive for A9 probes. The Cervista HPV HR assay can detect HPV-positive samples from those with hybrid capture borderline results but can produce false-positive results when tested for reactivity with A9 probes.

Keywords: HPV; Human papillomavirus; hybrid capture; invader

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1600-0463.2010.02639.x

Affiliations: Department of Microbiology, School of Medicine, University of Cádiz, Cádiz

Publication date: September 1, 2010

mksg/apm/2010/00000118/00000009/art00007
dcterms_title,dcterms_description,pub_keyword
6
5
20
40
5

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more